|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gnant M, Harbeck N and Thomssen C: St
Gallen 2011: Summary of the Consensus Discussion. Breast Care
(Basel). 136–141. 2011. View Article : Google Scholar
|
|
3
|
Dent R, Trudeau M, Pritchard KI, Hanna WM,
Kahn HK, Sawka CA, Lickley LA, Rawlinson E, Sun P and Narod SA:
Triple-negative breast cancer: Clinical features and patterns of
recurrence. Clin Cancer Res. 13:4429–4434. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Feng W, Liu S, Zhu R, Li B, Zhu Z, Yang J
and Song C: SOX10 induced Nestin expression regulates cancer stem
cell properties of TNBC cells. Biochem Biophys Res Commun.
485:522–528. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Idowu MO, Kmieciak M, Dumur C, Burton RS,
Grimes MM, Powers CN and Manjili MH: CD44(+)/CD24(−/low) cancer
stem/ progenitor cells are more abundant in triple-negative
invasive breast carcinoma phenotype and are associated with poor
outcome. Hum Pathol. 43:364–373. 2012. View Article : Google Scholar
|
|
6
|
Lendahl U, Zimmerman LB and McKay RD: CNS
stem cells express a new class of intermediate filament protein.
Cell. 60:585–595. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sejersen T and Lendahl U: Transient
expression of the intermediate filament nestin during skeletal
muscle development. J Cell Sci. 106:1291–1300. 1993.PubMed/NCBI
|
|
8
|
Kachinsky AM, Dominov JA and Miller JB:
Intermediate filaments in cardiac myogenesis: Nestin in the
developing mouse heart. J Histochem Cytochem. 43:843–847. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
About I, Laurent-Maquin D, Lendahl U and
Mitsiadis TA: Nestin expression in embryonic and adult human teeth
under normal and pathological conditions. Am J Pathol. 157:287–295.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zulewski H, Abraham EJ, Gerlach MJ, Daniel
PB, Moritz W, Müller B, Vallejo M, Thomas MK and Habener JF:
Multipotential nestin-positive stem cells isolated from adult
pancreatic islets differentiate ex vivo into pancreatic endocrine,
exocrine, and hepatic phenotypes. Diabetes. 50:521–533. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Vanderwinden JM, Gillard K, De Laet MH,
Messam CA and Schiffmann SN: Distribution of the intermediate
filament nestin in the muscularis propria of the human
gastrointestinal tract. Cell Tissue Res. 309:261–268. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Vogel W, Grünebach F, Messam CA, Kanz L,
Brugger W and Bühring HJ: Heterogeneity among human bone
marrow-derived mesenchymal stem cells and neural progenitor cells.
Haematologica. 88:126–133. 2003.PubMed/NCBI
|
|
13
|
Li L, Mignone J, Yang M, Matic M, Penman
S, Enikolopov G and Hoffman RM: Nestin expression in hair follicle
sheath progenitor cells. Proc Natl Acad Sci USA. 100:9958–9961.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Krum JM and Rosenstein JM: Transient
coexpression of nestin, GFAP, and vascular endothelial growth
factor in mature reactive astroglia following neural grafting or
brain wounds. Exp Neurol. 160:348–360. 1999. View Article : Google Scholar
|
|
15
|
Dahlstrand J, Collins VP and Lendahl U:
Expression of the class VI intermediate filament nestin in human
central nervous system tumors. Cancer Res. 52:5334–5341.
1992.PubMed/NCBI
|
|
16
|
Brychtova S, Fiuraskova M, Hlobilková A,
Brychta T and Hirnak J: Nestin expression in cutaneous melanomas
and melanocytic nevi. J Cutan Pathol. 34:370–375. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li H, Cherukuri P, Li N, Cowling V,
Spinella M, Cole M, Godwin AK, Wells W and DiRenzo J: Nestin is
expressed in the basal/myoepithelial layer of the mammary gland and
is a selective marker of basal epithelial breast tumors. Cancer
Res. 67:501–510. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tsujimura T, Makiishi-Shimobayashi C,
Lundkvist J, Lendahl U, Nakasho K, Sugihara A, Iwasaki T, Mano M,
Yamada N, Yamashita K, et al: Expression of the intermediate
filament nestin in gastrointestinal stromal tumors and interstitial
cells of Cajal. Am J Pathol. 158:817–823. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kleeberger W, Bova GS, Nielsen ME, Herawi
M, Chuang AY, Epstein JI and Berman DM: Roles for the stem cell
associated intermediate filament Nestin in prostate cancer
migration and metastasis. Cancer Res. 67:9199–9206. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Matsuda Y, Naito Z, Kawahara K, Nakazawa
N, Korc M and Ishiwata T: Nestin is a novel target for suppressing
pancreatic cancer cell migration, invasion and metastasis. Cancer
Biol Ther. 11:512–523. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nowak A, Grzegrzolka J, Paprocka M,
Piotrowska A, Rys J, Matkowski R and Dziegiel P: Nestin-positive
microvessel density is an independent prognostic factor in breast
cancer. Int J Oncol. 51:668–676. 2017.PubMed/NCBI
|
|
22
|
Zhao Z, Lu P, Zhang H, Xu H, Gao N, Li M
and Liu C: Nestin positively regulates the Wnt/β-catenin pathway
and the proliferation, survival and invasiveness of breast cancer
stem cells. Breast Cancer Res. 16:4082014. View Article : Google Scholar
|
|
23
|
Neradil J and Veselska R: Nestin as a
marker of cancer stem cells. Cancer Sci. 106:803–811. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gao N, Xu H, Liu C, Xu H, Chen G, Wang X,
Li Y and Wang Y: Nestin: Predicting specific survival factors for
breast cancer. Tumour Biol. 35:1751–1755. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu C, Chen B, Zhu J, Zhang R, Yao F, Jin
F, Xu H and Lu P: Clinical implications for nestin protein
expression in breast cancer. Cancer Sci. 101:815–819. 2010.
View Article : Google Scholar
|
|
26
|
Krüger K, Wik E, Knutsvik G, Nalwoga H,
Klingen TA, Arnes JB, Chen Y, Mannelqvist M, Dimitrakopoulou K,
Stefansson IM, et al: Expression of Nestin associates with BRCA1
mutations, a basal-like phenotype and aggressive breast cancer. Sci
Rep. 7:10892017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lakhani SR, Ellis IO, Schnitt SJ, Tan PH
and Vijver MJ: WHO Classification of Tumours of the Breast. IARC
Press; Lyon: 2012
|
|
28
|
Remmele W and Stegner HE: Recommendation
for uniform definition of an immunoreactive score (IRS) for
immunohistochemical estrogen receptor detection (ER-ICA) in breast
cancer tissue. Pathologe. 8:138–140. 1987.In German. PubMed/NCBI
|
|
29
|
Offersen BV, Borre M and Overgaard J:
Quantification of angiogenesis as a prognostic marker in human
carcinomas: A critical evaluation of histopathological methods for
estimation of vascular density. Eur J Cancer. 39:881–890. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fox SB, Leek RD, Smith K, Hollyer J,
Greenall M and Harris AL: Tumor angiogenesis in node-negative
breast carcinomas–relationship with epidermal growth factor
receptor, estrogen receptor, and survival. Breast Cancer Res Treat.
29:109–116. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Goldhirsch A, Ingle JN, Gelber RD, Coates
AS, Thürlimann B and Senn HJ; Panel members: Thresholds for
therapies: Highlights of the St Gallen International Expert
Consensus on the primary therapy of early breast cancer 2009. Ann
Oncol. 20:1319–1329. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Mueller-Holzner E, Fink V, Frede T and
Marth C: Immunohistochemical determination of HER2 expression in
breast cancer from core biopsy specimens: A reliable predictor of
HER2 status of the whole tumor. Breast Cancer Res Treat. 69:13–19.
2001. View Article : Google Scholar
|
|
33
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Krupkova O Jr, Loja T, Zambo I and
Veselska R: Nestin expression in human tumors and tumor cell lines.
Neoplasma. 57:291–298. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Piras F, Ionta MT, Lai S, Perra MT, Atzori
F, Minerba L, Pusceddu V, Maxia C, Murtas D, Demurtas P, et al:
Nestin expression associates with poor prognosis and triple
negative phenotype in locally advanced (T4) breast cancer. Eur J
Histochem. 55:e392011. View Article : Google Scholar
|
|
36
|
Parry S, Savage K, Marchiò C and
Reis-Filho JS: Nestin is expressed in basal-like and triple
negative breast cancers. J Clin Pathol. 61:1045–1050. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Mokrý J, Cízková D, Filip S, Ehrmann J,
Osterreicher J, Kolár Z and English D: Nestin expression by newly
formed human blood vessels. Stem Cells Dev. 13:658–664. 2004.
View Article : Google Scholar
|
|
38
|
Pula B, Olbromski M, Wojnar A,
Gomulkiewicz A, Witkiewicz W, Ugorski M, Dziegiel P and
Podhorska-Okolow M: Impact of SOX18 expression in cancer cells and
vessels on the outcome of invasive ductal breast carcinoma. Cell
Oncol (Dordr). 36:469–483. 2013. View Article : Google Scholar
|
|
39
|
Downes M and Koopman P: SOX18 and the
transcriptional regulation of blood vessel development. Trends
Cardiovasc Med. 11:318–324. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ikhapoh IA, Pelham CJ and Agrawal DK:
Sry-type HMG box 18 contributes to the differentiation of bone
marrow-derived mesenchymal stem cells to endothelial cells.
Differentiation. 89:87–96. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Xie L, Zeng X, Hu J and Chen Q:
Characterization of nestin, a selective marker for bone marrow
derived mesenchymal stem cells. Stem Cells Int. 2015:7620982015.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Narita K, Matsuda Y, Seike M, Naito Z,
Gemma A and Ishiwata T: Nestin regulates proliferation, migration,
invasion and stemness of lung adenocarcinoma. Int J Oncol.
44:1118–1130. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Flammiger A, Besch R, Cook AL, Maier T,
Sturm RA and Berking C: SOX9 and SOX10 but not BRN2 are required
for nestin expression in human melanoma cells. J Invest Dermatol.
129:945–953. 2009. View Article : Google Scholar
|
|
44
|
Yang XR, Xu Y, Yu B, Zhou J, Qiu SJ, Shi
GM, Zhang BH, Wu WZ, Shi YH, Wu B, et al: High expression levels of
putative hepatic stem/progenitor cell biomarkers related to tumour
angio-genesis and poor prognosis of hepatocellular carcinoma. Gut.
59:953–962. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Qin Q, Sun Y, Fei M, Zhang J, Jia Y, Gu M,
Xia R, Chen S and Deng A: Expression of putative stem marker nestin
and CD133 in advanced serous ovarian cancer. Neoplasma. 59:310–315.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
He H, Niu CS and Li MW: Correlation
between glioblastoma stem-like cells and tumor vascularization.
Oncol Rep. 27:45–50. 2012.
|
|
47
|
Nambirajan A, Sharma MC, Gupta RK, Suri V,
Singh M and Sarkar C: Study of stem cell marker nestin and its
correlation with vascular endothelial growth factor and
microvascular density in ependymomas. Neuropathol Appl Neurobiol.
40:714–725. 2014. View Article : Google Scholar
|
|
48
|
Hlobilkova A, Ehrmann J, Knizetova P,
Krejci V, Kalita O and Kolar Z: Analysis of VEGF, Flt-1, Flk-1,
nestin and MMP-9 in relation to astrocytoma pathogenesis and
progression. Neoplasma. 56:284–290. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Ricci-Vitiani L, Pallini R, Biffoni M,
Todaro M, Invernici G, Cenci T, Maira G, Parati EA, Stassi G,
Larocca LM, et al: Tumour vascularization via endothelial
differentiation of glioblastoma stem-like cells. Nature.
468:824–828. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Wang R, Chadalavada K, Wilshire J, Kowalik
U, Hovinga KE, Geber A, Fligelman B, Leversha M, Brennan C and
Tabar V: Glioblastoma stem-like cells give rise to tumour
endothelium. Nature. 468:829–833. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Ping YF and Bian XW: Consice review:
Contribution of cancer stem cells to neovascularization. Stem
Cells. 29:888–894. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Liu TJ, Sun BC, Zhao XL, Zhao XM, Sun T,
Gu Q, Yao Z, Dong XY, Zhao N and Liu N: CD133+ cells
with cancer stem cell characteristics associates with vasculogenic
mimicry in triple-negative breast cancer. Oncogene. 32:544–553.
2013. View Article : Google Scholar
|
|
53
|
Mohammed RA, Ellis IO, Mahmmod AM, Hawkes
EC, Green AR, Rakha EA and Martin SG: Lymphatic and blood vessels
in basal and triple-negative breast cancers: Characteristics and
prognostic significance. Mod Pathol. 24:774–785. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Krüger K, Stefansson IM, Collett K, Arnes
JB, Aas T and Akslen LA: Microvessel proliferation by co-expression
of endothelial nestin and Ki-67 is associated with a basal-like
phenotype and aggressive features in breast cancer. Breast.
22:282–288. 2013. View Article : Google Scholar
|
|
55
|
Lacroix M and Leclercq G: Relevance of
breast cancer cell lines as models for breast tumours: An update.
Breast Cancer Res Treat. 83:249–289. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Dzięgiel P, Owczarek T, Plazuk E,
Gomułkiewicz A, Majchrzak M, Podhorska-Okołów M, Driouch K,
Lidereau R and Ugorski M: Ceramide galactosyltransferase (UGT8) is
a molecular marker of breast cancer malignancy and lung metastases.
Br J Cancer. 103:524–531. 2010. View Article : Google Scholar
|
